USPTO serial 87402113
X-SYNERGY
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAMONT, JOHN CHRISTOPHER
- Law office
- TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with X-SYNERGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ai Tang Chang
AI-TANG CHANG PERKINS COIE LLP3150 PORTER DRIVEPALO ALTO, CA 94304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical drug development services not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical product evaluation not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical products development not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical research and development not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Technical research in the field of pharmaceutical studies not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Analysis of the mode of action of chemical combinations on animals; Chemical, biochemical, biological and bacteriological research and analysis not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Providing a website featuring information about investigational medical devices, diagnostics and drugs; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Research on the subject of pharmaceuticals not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2019 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Feb 15, 2019 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Feb 15, 2019 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jan 7, 2019 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Jul 14, 2018 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jul 14, 2018 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jul 14, 2018 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jul 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 11, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 11, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 23, 2018 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 23, 2018 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 23, 2018 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jun 22, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 22, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 22, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 22, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 1, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 10, 2017 | NWAP | NEW APPLICATION ENTERED | — |